Aspirin dose for the prevention of cardiovascular disease: a systematic review.

@article{Campbell2007AspirinDF,
  title={Aspirin dose for the prevention of cardiovascular disease: a systematic review.},
  author={Charles Leo Campbell and Susan S Smyth and Gilles Montalescot and Steven R. Steinhubl},
  journal={JAMA},
  year={2007},
  volume={297 18},
  pages={
          2018-24
        }
}
CONTEXT More than 50 million US adults take aspirin regularly for long-term prevention of cardiovascular disease, typically either 81 mg/d or 325 mg/d. Controversy remains regarding the most appropriate long-term daily dose. OBJECTIVE To review the mechanism of action of aspirin and the clinical literature for relationships among aspirin dosage, efficacy, and safety. EVIDENCE ACQUISITION A systematic review of the English-language literature was undertaken using MEDLINE and EMBASE (searched… CONTINUE READING
BETA

Similar Papers

Citations

Publications citing this paper.
SHOWING 1-10 OF 188 CITATIONS, ESTIMATED 43% COVERAGE

Aspirin, clopidogrel, and ticagrelor in acute coronary syndromes.

  • The American journal of cardiology
  • 2013
VIEW 11 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Aspirin and age-related macular degeneration: positives versus negatives.

  • Expert opinion on drug safety
  • 2014
VIEW 5 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Optimale Thrombozytenaggregationshemmung nach koronarer Stentimplantation

  • Herz Kardiovaskuläre Erkrankungen
  • 2008
VIEW 9 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

FILTER CITATIONS BY YEAR

2007
2019

CITATION STATISTICS

  • 5 Highly Influenced Citations

  • Averaged 8 Citations per year from 2017 through 2019

References

Publications referenced by this paper.
SHOWING 1-10 OF 62 REFERENCES